Anti-RSV monoclonal antibody formulation

ZA202510099BActive Publication Date: 2026-09-30MEDIMMUNE LTD

View PDF 0 Cites 0 Cited by

Patent Information

Application Number: ZA202510099
Authority / Receiving Office: ZA · ZA
Patent Type: Patents
Current Assignee / Owner
Priority Date: 2017-03-01
Filing Date: 2025-11-26
Publication Date: 2026-09-30
Estimated Expiration: 2045-11-26

Application Information

Patent Timeline

01 Mar 2017

Priority

26 Nov 2025

Application

ZA202510099

30 Sep 2026

Publication

ZA202510099B

IPC: A61K; C07K; A61P

Inventors: LOBO, BRIAN; GOLDBERG, DEBORAH

Get more patent work done with AI

Run novelty searches—or use them for FTO, design risk, drafting and technical problem-solving.

Explore More Agents

Novelty Search
Search existing technologies and assess novelty
↗
FTO
Analyze whether a product may infringe others' patents
↗
Design FTO
Check prior-design risk for exterior design
↗
Drafting
Draft patent application text based on a technical solution
↗
Find Solutions with TRIZ
Generate feasible solution to solve your technical challenge
↗
IP MCP Servers
Connect trusted patent search and cited evidence to Claude, Cursor or your own AI workflow
↗

Patent Text Reader

Abstract

The present invention provides a formulation comprising: (i) an anti-RSV monoclonal antibody; and (ii) an ionic excipient; wherein the monoclonal antibody is present at a concentration of about 50mg / ml or greater and the ionic excipient is present at a concentration of between 50 and 150 mM and the formulation has a pH of about 5.5 to about 7.5.

Need to check novelty before this filing date? Find Prior Art